Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,230,428
-
Share change
-
+7,920,073
-
Total reported value
-
$17,739,000
-
Price per share
-
$1.58
-
Number of holders
-
20
-
Value change
-
+$12,848,640
-
Number of buys
-
14
-
Number of sells
-
3
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q1 2020
As of 31 Mar 2020,
LEAP THERAPEUTICS INC - COM (LPTX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,230,428 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Sio Capital Management, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., 683 Capital Management, LLC, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and PERSONAL CFO SOLUTIONS, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.